The strongest hypothesis relating to the mechanism is that the increased level of IL-6 in cancer patients is due to excessive production from the tumor, and reflects the increase in serum levels of IL-6 as a biologic characteristic of the tumor However, the role of IL-6 in the growth of head and neck cancers is not yet well known. This evidence concerns the gene IL6 and head and neck cancer.